144 related articles for article (PubMed ID: 9647303)
1. Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial.
Latif AZ; Signorini D; Gregor A; Grant R; Ironside JW; Whittle IR
J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):747-50. PubMed ID: 9647303
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Medical Research Council and a newly developed prognostic index in patients with malignant glioma: how useful are prognostic indices in routine clinical practice?
Akman F; Cooper RA; Sen M; Tanriver Y; Kentli S
J Neurooncol; 2002 Aug; 59(1):39-47. PubMed ID: 12222837
[TBL] [Abstract][Full Text] [Related]
3. The costs of managing patients with malignant glioma at a neuro-oncology clinic.
Latif AZ; Signorini D; Gregor A; Whittle IR
Br J Neurosurg; 1998 Apr; 12(2):118-22. PubMed ID: 11013662
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic astrocytoma and glioblastoma: pion irradiation with the dynamic conformation technique at the Swiss Institute for Nuclear Research (SIN).
Greiner R; Blattmann H; Thum P; Bösiger P; Coray A; Kann R; Lahtinen T; Reinhardt H; von Essen CF; Zimmermann A
Radiother Oncol; 1990 Jan; 17(1):37-46. PubMed ID: 2108474
[TBL] [Abstract][Full Text] [Related]
5. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison.
Tanaka M; Ino Y; Nakagawa K; Tago M; Todo T
Lancet Oncol; 2005 Dec; 6(12):953-60. PubMed ID: 16321763
[TBL] [Abstract][Full Text] [Related]
6. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
Würschmidt F; Bünemann H; Heilmann HP
Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
[TBL] [Abstract][Full Text] [Related]
8. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
9. [Results of conventional radiotherapy in malignant gliomas:].
Shibamoto Y; Yamashita J; Takahashi M; Yamasaki T; Kikuchi H; Abe M
Gan No Rinsho; 1989 Sep; 35(11):1240-6. PubMed ID: 2554004
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party.
J Neurooncol; 1990 Aug; 9(1):47-55. PubMed ID: 2213115
[TBL] [Abstract][Full Text] [Related]
11. Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.
Daniels TB; Brown PD; Felten SJ; Wu W; Buckner JC; Arusell RM; Curran WJ; Abrams RA; Schiff D; Shaw EG
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):218-24. PubMed ID: 21549518
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
13. 5-year survival and clinical prognostic factors in progressive supratentorial diffuse "low-grade" astrocytoma: a retrospective analysis of 46 cases.
Schuurman PR; Troost D; Verbeeten B; Bosch DA
Acta Neurochir (Wien); 1997; 139(1):2-7. PubMed ID: 9059704
[TBL] [Abstract][Full Text] [Related]
14. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.
Bleehen NM; Stenning SP
Br J Cancer; 1991 Oct; 64(4):769-74. PubMed ID: 1654987
[TBL] [Abstract][Full Text] [Related]
15. Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times.
Goetz C; Riva P; Poepperl G; Gildehaus FJ; Hischa A; Tatsch K; Reulen HJ
J Neurooncol; 2003 May; 62(3):321-8. PubMed ID: 12777085
[TBL] [Abstract][Full Text] [Related]
16. Gliadel therapy given for first resection of malignant glioma: a single centre study of the potential use of Gliadel.
Whittle IR; Lyles S; Walker M
Br J Neurosurg; 2003 Aug; 17(4):352-4. PubMed ID: 14579902
[TBL] [Abstract][Full Text] [Related]
17. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
[TBL] [Abstract][Full Text] [Related]
18. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
20. Treatment by a specialist surgical neuro-oncologist does not provide any survival advantage for patients with a malignant glioma.
Latif AZ; Signorini DF; Whittle IR
Br J Neurosurg; 1998 Feb; 12(1):29-32. PubMed ID: 11013644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
